GSDMD and gout: Notably, the function and effect of GSDMD on other pyroptosis-associated diseases require closer study, such as Familial Mediterranean fever (FMF) (30–32), gout (33), Alzheimer’s disease (AD) (34), and Ischemic brain injury (35–37).